Although RAD54B, BLM and CHEK2 genes are mutated in CRC, they are also mutated in numerous additional cancers including pancreatic (~16.5% collectively), prostate (~16.7%), melanoma (~15.1%) and endometrial (~8.8%). This evidence concerns the gene BLM and colorectal carcinoma.